Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-12

Clinical Trial Update: Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures [Phase 4]

View source ↗

Summary

A Phase 4 trial compared adjunctive levetiracetam to topiramate in adults with refractory partial-onset seizures. The study is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • Topiramate (Topiramate)

Snippet

Sponsor: UCB Korea Co., Ltd. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2016-02-12